Talis BiomedicalTLIS
13F holders, Q4 2024 (December 31)1holders −1
1new positions
2sold out
$1.86avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Talis Biomedical Corp. (TLIS) in their 13F filings, down 1 from Q3 2024. 1 opened new positions and 2 sold out. The largest holder was Synergy Asset Management, LLC ($26).
- Company
- Talis Biomedical Corp.
- CUSIP
- 87424L207
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $26 |
| Exits | 2 | $460K |
All 13F filers, Q3 2024 → Q4 2024: 14 shares bought and 248,849 shares sold, net −248,835 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Synergy Asset Management, LLC | 0.00% | New | 14 | $26 |
"% of holder's portfolio" is TLIS's weight in each manager's 13F, not the share of Talis Biomedical Corp. the manager owns.